Recombinant Clotting Factors: A Review of Current Clinical Status

ISSN： 1173-8804

Source： BioDrugs, Vol.13, Iss.4, 2000-04, pp. : 289-298

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiviral Immunotherapy: A Review of Current Status

By desJardin J.A. Snydman D.R.

BioDrugs, Vol. 9, Iss. 6, 1998-06 ,pp. : 487-507

Adis International

Access to resources Recommend Favorite

Efficacy of Alemtuzumab in Organ Transplantation: Current Clinical Status

By Ciancio Gaetano Burke George W. Warque Maria E. Miller Joshua

BioDrugs, Vol. 20, Iss. 2, 2006-01 ,pp. : 85-92

Adis International

Access to resources Recommend Favorite

A Current Review of Juvenile Pemphigus Vulgaris: Analysis of Data on Clinical Outcomes

By Asarch Adam

American Journal of Clinical Dermatology, Vol. 11, Iss. 1, 2010-02 ,pp. : 21-33

Adis International

Access to resources Recommend Favorite

Treatment of Drug-Induced Agranulocytosis with Haematopoietic Growth Factors: A Review of the Clinical Experience

By Vial T. Gallant C. Choqu-Kastylevsky G. descotes J.

BioDrugs, Vol. 11, Iss. 3, 1999-03 ,pp. : 185-200

Adis International

Access to resources Recommend Favorite

Recombinant Plasminogen Activators: A Comparative Review of the Clinical Pharmacology and Therapeutic Use of Alteplase and Reteplase

By Moser M. Kohler B. Schmittner M. Bode C.

BioDrugs, Vol. 9, Iss. 6, 1998-06 ,pp. : 455-463

Adis International

Access to resources Recommend Favorite